Endocytosis machinery is involved in aggregation of proteins with expanded polyglutamine domains

Anatoli B Meriin1, XiaoQian Zhang, Ilya M Alexandrov

  • 1Department of Biochemistry, Boston University Medical School, Boston, Massachusetts, USA.

Insights

Cellular protein aggregation, linked to disease, is influenced by the endocytic complex (EC). Late-stage EC components promote polyglutamine aggregation, while early-stage components do not, revealing a key cellular pathway.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Background:

  • Protein misfolding and aggregation are implicated in cellular toxicity and various pathologies.
  • Understanding the cellular mechanisms governing protein aggregation is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of cellular factors, specifically the endocytic complex (EC), in protein aggregation using polyglutamine domain-containing polypeptides.
  • To determine whether different stages of EC maturation influence the aggregation process.

Main Methods:

  • Utilized model polypeptides with polyglutamine domains in both yeast and mammalian cell systems.
  • Investigated the impact of mutations affecting the endocytic vesicle formation complex in yeast.
  • Examined the localization of EC components within protein aggregates.
  • Manipulated actin polymerization dynamics and EC component levels (e.g., Arp2, N-WASP) in both cell types.

Main Results:

  • Mutations in late-stage endocytic complex (EC) components reduced polyglutamine aggregation in yeast.
  • Specific late-stage EC proteins (Sla1, Sla2, Pan1) were found within polyglutamine aggregates.
  • Inhibition of actin polymerization enhanced polyglutamine aggregation in both yeast and mammalian cells.
  • Disruption of EC scaffolding (N-WASP) suppressed aggregation, while depletion of actin mediator Arp2 enhanced it.

Conclusions:

  • The endocytic complex (EC) plays a significant role in the aggregation of cytosolic polypeptides containing polyglutamine domains.
  • Late-stage EC components and actin dynamics are critical regulators of polyglutamine aggregation.
  • Targeting EC function or actin polymerization may offer therapeutic avenues for protein aggregation disorders.

Related Concept Videos

Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
Protein Translocation Machinery on the ER Membrane01:28

Protein Translocation Machinery on the ER Membrane

The translocon complex situated on the ER membrane is the main gateway for the protein secretory pathway. It facilitates the transport of nascent peptides into the ER lumen and their insertion into the ER membrane.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
Clathrin Coated Vesicles01:12

Clathrin Coated Vesicles

Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Coat Assembly and GTPases01:33

Coat Assembly and GTPases

Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...